Estimation of HIV Incidence in a Large, Community-Based, Randomized Clinical Trial: NIMH Project Accept (HIV Prevention Trials Network 043)

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Laeyendecker, Oliver ^a,b   Piwowar Manning, Estelle ^b   Fiamma, Agnes ^c   Kulich, Michal ^d   Donnell, Deborah ^e,f   Bassuk, Deb ^e   Mullis, Caroline E ^b,p   Chin, Craig ^e   Swanson, Priscilla ^g   Hackett, John ^g   Clarke, William ^b   Marzinke, Mark ^b   Szekeres, Greg ^c   Gray, Glenda ^h   Richter, Linda ⁱ   Alexandre, Michel W ^j   Chariyalertsak, Suwat ^k   Chingono, Alfred ^l   Celentano, David D ^m   Morin, Stephen F ⁿ   Sweat, Michael ^o   Coates, Thomas ^c   Eshleman, Susan H ^b   more..

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CHARLES UNIVERSITY   (Czech Republic)

^e Fred Hutchinson Cancer Research Center   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g ABBOTT DIAGNOSTICS   (United States)

^h UNIVERSITY OF THE WITWATERSRAND   (South Africa)

ⁱ HUMAN SCIENCES RESEARCH COUNCIL   (South Africa)

^j MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^k CHIANG MAI UNIVERSITY   (Thailand)

^l UNIV OF ZIMBABWE MEDICAL SCHOOL   (Zimbabwe)

^m JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^p GEORGETOWN UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HIGH THROUGHPUT SCREENING; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOASSAY; INCIDENCE; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; RANDOMIZED CONTROLLED TRIAL; UNINDEXED SEQUENCE; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS LOAD;

EID: 84880063002     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068349     Document Type: Article

References (24)

1. Khumalo-Sakutukwa G, Morin SF, Fritz K, Charlebois ED, van Rooyen H, et al. (2008) Project Accept (HPTN 043): a community-based intervention to reduce HIV incidence in populations at risk for HIV in sub-Saharan Africa and Thailand. J Acquir Immune Defic Syndr 49: 422-431.
2. Sweat M, Morin S, Celentano D, Mulawa M, Singh B, et al. (2011) Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study. Lancet Infect Dis 11: 525-532.
3. Genberg BL, Kulich M, Kawichai S, Modiba P, Chingono A, et al. (2008) HIV risk behaviors in sub-Saharan Africa and Northern Thailand: baseline behavioral data from Project Accept. J Acquir Immune Defic Syndr 49: 309-319.
4. Brookmeyer R, Laeyendecker O, Donnell D, Eshleman S (2013) Cross-sectional HIV incidence estimation in HIV prevention research. J Acquir Immune Defic Syndr, In Press.
5. Dobbs T, Kennedy S, Pau CP, McDougal JS, Parekh BS, (2004) Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Microbiol 42: 2623-2628.
6. UNAIDS Reference Group on Estimates Modeling and Projections (2006) Statement on the use of the BED assay for estimation of HIV-1 incidence or epidemic monitoring. Weekly Epidemiol Rec 81: 33-40.
7. Piwowar-Manning E, Fiamma A, Laeyendecker O, Kulich M, Donnell D, et al. (2011) HIV surveillance in a large, community-based study: results from the pilot study of Project Accept (HIV Prevention Trials Network 043). BMC Infect Dis 11: 251.
8. Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, et al. (2013) HIV incidence determination in the United States: A multiassay approach. J Infect Dis 207: 232-239.
9. Eshleman SH, Hughes JP, Laeyendecker O, Wang J, Brookmeyer R, et al. (2013) Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study. J Infect Dis, 207, 223-231.
10. Laeyendecker O, Wang L, Hughes JP, Cummings V, Piwowar-Manning E, et al. (2013) Use of a multi-assay algorithm for cross-sectional HIV incidence estimation in HPTN 061 (the Brothers Study). 20th Conf. on Retroviruses and Opportunistic Infections March 3-6, Atlanta, GA: Abstract 1053.
11. Masciotra S, Dobbs T, Candal D, Hanson D, Delaney K, et al. (2010) Antibody avidity-based assay for identifying recent HIV-1 infections based on Genetic Systems TM 1/2 plus O EIA. 17th Conf. on Retroviruses and Opportunistic Infections February 16-19, Abstract 937.
12. Brookmeyer R, Konikoff J, Laeyendecker O, Eshleman SH, (2013) HIV incidence estimation using multiple biomarkers. Amer J Epidemiol 177: 264-272.
13. Laeyendecker O, Brookmeyer R, Kulich M, Quinn T, Konikoff J, et al. (2013) Accurate cross-sectional HIV incidence testing. 20th Conf. on Retroviruses and Opportunistic Infections March 3-6, Atlanta, GA: Abstract 164.
14. Kulich M, Laeyendecker O, Eshleman SH, Koma'reka A, Omelkaa M, et al. (2013) Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation. Submitted.
15. Laeyendecker O, Kulich M, Donnell D, Komárek A, Omelka M, et al. (2013) Identification of an optimal multi-assay algorithm to determine HIV incidence in the Southern African communities of NIMH Project ACCEPT (HPTN 043). Submitted.
16. Hemelaar J, Gouws E, Ghys PD, Osmanov S, (2011) Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 25: 679-689.
17. Mullis C, Munshwa S, Grabowski M, Serwadda D, Brookmeyer R, et al. (2012) HIV sequence differences are associated with false-recent misclassification with the BED capture enzyme immunoassay in subtype D HIV. 19th Conf. on Retroviruses and Opportunistic Infections March 5-8, Seattle, WA: Abstract 541.
18. Laeyendecker O, Brookmeyer R, Oliver AE, Mullis CE, Eaton KP, et al. (2012) Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay. AIDS Res Hum Retroviruses 28: 816-822.
19. Coates T, Eshleman SH, Chariyalertsak S, Chingono A, Gray G, et al. (2013) Findings on estimates of community-level HIV incidence in HPTN 043 (Project Accept). 20th Conf. on Retroviruses and Opportunistic Infections March 3-6, Atlanta, GA: Abstract 30.
20. Collinson-Streng AN, Redd AD, Sewankambo NK, Serwadda D, Rezapour M, et al. (2009) Geographic HIV type 1 subtype distribution in Rakai district, Uganda. AIDS Res Hum Retroviruses 25: 1045-1048.
21. Marzinke MA, Breaud A, Clarke W (2012) Development of a high resolution accurate mass method for the multiplexed monitoring of antiretroviral agents in human serum. 47th Meeting of the Academy of Clinical Laboratory Physicians and Scientists June, Milwaukee, WI.
22. Rehle TM, Hallett TB, Shisana O, Pillay-van Wyk V, Zuma K, et al. (2010) A decline in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008. PLoS One 5(6): e11094.
23. Brookmeyer R, Quinn TC, (1995) Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. Am J Epidemiol 141: 166-172.
24. Wendel SK, Mullis CE, Eshleman SH, Blankson JN, Moore RD, et al. (2013) Effect of natural and ARV-Induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in Individuals with clade B HIV infection. PLoS One 8(2): 55525.